Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer

Table 3

Patient characteristics and treatment outcomes (High-risk patients).

			RT-group	CCRT-group	𝑃-value
Patient characteristics	Number of patients		34	34
	Age (mean)		51.3	50.1
	Clinical stage	IA2	0	0
		IB	7	12
		IIA	9	2
		IIB	18	20
	Histology	Squamous cell	21	25
		Adenocarcinoma	13	8
		Adenosquamous	0	1
		Others	0	0
Treatment outcome	Duration of radiotherapy	Days	38	38	NS
	Patients with recurrence (%)		16 (47.0)	9 (26.5)	NS
	PFS (months)	Mean	22.6	29.5	NS
	OS (months)	Mean	29.7	34.2	.0364

PFS: progression-free survival, OS: overall survival, CCRT: concurrent chemoradiotherapy, RT: radiotherapy.